Larixin

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

28 API Suppliers, 20 USDMF, 5 JDMF, 1 EU WC, 5 NDC API, 3 Listed Suppliers

DEVELOPMENTS

14 Drugs in Development

14 Drugs in Development

INTERMEDIATES

4 Intermediate Suppliers

4 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

185 FDF Dossiers, 97 FDA Orange Book, 19 Europe, 6 Canada, 2 South Africa, 61 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - EQ 250MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - EQ 333MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - EQ 500MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - EQ 750MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

3 Rochem International Inc, 6 SPI Pharma, 1 Pharm-RX Chemical, 4 Gangwal Healthcare, 5 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 3 Kirsch Pharma, 3 Dr. Paul Lohmann GmbH & Co. KGaA, 4 ACG Worldwide, 6 Actylis, 1 Aeon Procare, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 9 BASF, 2 CD Formulation, 1 Clariant, 7 DFE Pharma, 2 Finar, 9 Gangwal Chemicals, 1 Gloria Interchem, 1 Ideal Cures, 4 Ingredion Pharma Solutions, 16 Kerry, 4 Keval Exports, 1 Kima Chemical, 3 Lonza Capsugel, 13 Microlex e.U, 1 Nanjing Bold Chemical, 1 Neelkanth MineChem, 2 Nitika Pharmaceutical Specialities, 2 Pharmatrans-Sanaq, 5 Pluviaendo, 4 Prachin Pharmachem, 1 Qualicaps, 23 Roquette, 8 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 11 Sigachi Industries, 4 Silverline Chemicals, 1 The Dow Chemical Company, 1 Valens Pharmachem, 4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

44 Fillers, Diluents & Binders, 29 Thickeners and Stabilizers, 29 Direct Compression, 24 Disintegrants & Superdisintegrants, 24 Granulation, 18 Solubilizers, 16 Lubricants & Glidants, 14 Coating Systems & Additives, 14 Taste Masking, 12 Parenteral, 12 Co-Processed Excipients, 11 Topical, 10 Film Formers & Plasticizers, 8 Empty Capsules, 7 Rheology Modifiers, 7 Emulsifying Agents, 7 Controlled & Modified Release, 7 Chewable & Orodispersible Aids, 5 Surfactant & Foaming Agents, 5 API Stability Enhancers

DIGITAL CONTENT

111 News #PharmaBuzz

111 News #PharmaBuzz

GLOBAL SALES INFORMATION

12 US Medicaid Prescriptions, 10 Regulatory FDF Prices

MARKET PLACE

14 APIs, 4 FDF Dossiers

REF. STANDARDS & IMPURITIES

12 Others

12 Others

Xls

Filters

Larixin

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Looking for Larixin? Find Coloring Agents used in Larixin to address drug delivery challenges on PharmaCompass.

Larixin

ACCESS ALL DATA

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

28 API Suppliers

20 USDMF

5 JDMF

1 EU WC

5 NDC API

3 Listed Suppliers

DEVELOPMENTS

14 Drugs in Development

INTERMEDIATES

4 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

185 FDF Dossiers

97 FDA Orange Book

19 Europe

6 Canada

2 South Africa

61 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - EQ 250MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE;ORAL - EQ 333MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE;ORAL - EQ 500MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE;ORAL - EQ 750MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

3 Rochem International Inc

6 SPI Pharma

1 Pharm-RX Chemical

4 Gangwal Healthcare

5 Nanjing Well Pharmaceutical

1 Pfanstiehl

3 Kirsch Pharma

3 Dr. Paul Lohmann GmbH & Co. KGaA

4 ACG Worldwide

6 Actylis

1 Aeon Procare

7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

1 Ashland

9 BASF

2 CD Formulation

1 Clariant

7 DFE Pharma

2 Finar

9 Gangwal Chemicals

1 Gloria Interchem

1 Ideal Cures

4 Ingredion Pharma Solutions

16 Kerry

4 Keval Exports

1 Kima Chemical

3 Lonza Capsugel

13 Microlex e.U

1 Nanjing Bold Chemical

1 Neelkanth MineChem

2 Nitika Pharmaceutical Specialities

2 Pharmatrans-Sanaq

5 Pluviaendo

4 Prachin Pharmachem

1 Qualicaps

23 Roquette

8 Seppic

4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

11 Sigachi Industries

4 Silverline Chemicals

1 The Dow Chemical Company

1 Valens Pharmachem

4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

44 Fillers, Diluents & Binders

29 Thickeners and Stabilizers

29 Direct Compression

24 Disintegrants & Superdisintegrants

24 Granulation

18 Solubilizers

16 Lubricants & Glidants

14 Coating Systems & Additives

CAPSULE;ORAL - EQ 250MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE;ORAL - EQ 333MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE;ORAL - EQ 500MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE;ORAL - EQ 750MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons